Biopharma Contract Market Update
CMOs and CDMOs expanded their services and facilities in 2019 and early 2020.
Contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) continue to grow and expand to keep up with the latest advances and breakthroughs in services and technology for their clients. The following are some notable acquisitions, expansions, and industry partnerships that have occurred in recent months.
Read this article in BioPharm International’s Outsourcing Resources February 2020 eBook.
Article Details
BioPharm International
eBook: Outsourcing Resources, February 2020
February 2020
Pages: 28–30
Citation
When referring to this article, please cite it as The Editors of BioPharm International, “Biopharma Contract Market Update," BioPharm International Outsourcing Resources eBook (February 2020).
VERAXA and Voyager to Create Combined Business for Advancing Pipeline of Next-Gen Cancer Therapies
April 23rd 2025The proposed business combination would create a publicly traded, clinical-stage biopharmaceutical company that will focus on developing a pipeline of next-generation cancer therapies.
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
